Evaluation of Artemisia Annua and Moringa
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections
Eligibility Criteria
Inclusion Criteria:
- Participant is 18 years of age and above
- Participant is HIV positive
- Participant is on HAART first line for at least one year.
- Participant is mentally sound
- Participant is living within 60 km radius from the clinic and will be remaining within the radius of 60 km from the clinic during the study period
h) Participant has a CD4 count less than 350cells/µl i.)Participant has normal haematological and biochemical indices J) ability to use phone SMS messaging K) Participant has signed the informed consent form
Exclusion Criteria:
- Participant is pregnant
- Participant does not consent to study
- Participant with opportunistic infection
- Participants using other herbal medicines
- Participant living outside the radius of 60 km from the clinic
Sites / Locations
- Mbarara Regional Referral Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Control Arm
Intervention Arm 1
Intervention Arm 2
Participants will be on routine HAART only. No Artemisia Annua, Moringa oleifera will be given.
Participants will be given HAART and Artemisia annua leaf powder 4 g per day. They will only receive Artemisia Annua, Moringa oleifera will not be given.
Participants will be given HAART with Artemisia annua leaf powder of 4 grams per day and Moringa oleifera leaf powder of 10 grams per day. Both Artemisia Annua, Moringa oleifera will be given.